Concepedia

Linne Svensson

LS

Statistics

Publications

5

Citations

419

H-Index

5

Active since

1994

Affiliations

Pfizer (United States)(Current)

Linne Svensson is an author at Pfizer (United States) specializing in inflammatory signaling, pharmacology, and anti-inflammatory therapeutics.

Publications per year

1994–2004

5

Publications

5

Deficiency of the Stress Kinase P38α Results in Embryonic Lethality

Melanie Allen, Linne Svensson, Marsha L. Roach et al. · The Journal of Experimental Medicine · 2000 · 268 citations · Full text

, , +17

Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. II. Inhibition of IL-1 <i>beta</i> production from ATP-treated monocytes and macrophages.

Ronald E. Laliberte, David G. Perregaux, Linne Svensson et al. · The Journal of Immunology · 1994 · 69 citations

, , +17

Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. I. Mechanism and evidence of functional significance.

Patricia A. McNiff, Linne Svensson, Christopher J. Pazoles et al. · The Journal of Immunology · 1994 · 40 citations · Full text

, , +17

Benzimidazolone p38 inhibitors

Mark A. Dombroski, Michael A. Letavic, Kim F. McClure et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 29 citations · Full text

Inhibition of Cytokine Activation Processes In Vitro by Tenidap, a Novel Anti-Inflammatory Agent

Patricia A. McNiff, Ronald E. Laliberte, Linne Svensson et al. · Cytokine · 1995 · 13 citations

, , +14

1–5 of 5